Brant A. Inman, Thomas J. Sebo, Xavier Frigola, Haidong Dong, Eric J. Bergstralh, Igor Frank, Yves Fradet, Louis Lacombe and Eugene D. Kwon PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata Cancer 109
Article first published online: 5 MAR 2007 | DOI: 10.1002/cncr.22588
PD-L1 (programmed death ligand 1, B7-H1) is a cell surface glycoprotein that can impair T-cell function. PD-L1 is aberrantly expressed by multiple human malignancies and has been shown to carry a highly unfavorable prognosis in patients with kidney cancer. The role of PD-L1 was evaluated as a mechanism for local stage progression in urothelial carcinoma of the bladder.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field